Protagonist Therapeutics, Inc.

Protagonist Therapeutics Inc. is a biopharmaceutical company dedicated to the discovery and development of peptide-based therapeutics. These therapeutics are designed to address significant unmet medical needs, focusing on diseases that involve critical biological pathways regulated by peptides and proteins. Utilizing a proprietary technology platform, Protagonist Therapeutics develops solutions for conditions such as inflammatory bowel disease, myeloproliferative neoplasms, and other serious health disorders. The company’s innovative approach aims to combine the efficacy and safety of peptide drugs with novel mechanisms of action, providing targeted treatments that can potentially improve patient outcomes. Located in Newark, California, Protagonist Therapeutics plays a vital role in the biotechnology industry, contributing to advances in medical treatments and the broader healthcare sector. Its research and development efforts are significant, offering potential new therapies that could positively impact both patients’ lives and healthcare practices.